Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations
BOSTON--(BUSINESS WIRE)--Jun. 9, 2021-- Vertex Pharmaceuticals Incorporated (Nasdaq
Three FDA Advisers Quit Over Agency Approval of Aduhelm
FRIDAY, June 11, 2021 -- Three members of a U.S. Food and Drug Administration advisory committee have resigned after the agency this week approved a new drug for Alzheimer disease despite a lack of
Will People Really Need a Yearly COVID Booster Vaccine?
FRIDAY, June 11, 2021 -- As the number of people fully immunized against COVID-19 rises into the hundreds of millions, immunologists and infectious disease experts now are pondering a new question i
Amazon Tribe Could Hold Key to Health of Aging Brains
FRIDAY, May 28, 2021 -- A native South American population that lives a pre-industrial lifestyle may have a slower rate of brain aging than the typical Westerner, a new study finds.
The study focus
Another Study Finds Routine Vaccines Safe for Kids, Adults
FRIDAY, May 28, 2021 -- If more proof of the safety of vaccines is needed, a new study delivers fresh evidence that they carry few harms for children, adults and pregnant women.
"This in-depth
FDA Approves Myfembree
FDA Approves Myfembree as the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids
BASEL, Switzerland and NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer In